Spinal Chloroprocaine Solutions: Density at 37° C and pH Titration

Anesthesia and Analgesia

Volumn 98, Issue 1, 2004, Pages 70-74

  Na, Kimberly B ^a   Kopacz, Dan J ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BICARBONATE; BISULFITE; CHLOROPROCAINE; GLUCOSE; LIDOCAINE; WATER;

ANESTHESIA; ARTICLE; CEREBROSPINAL FLUID; CLINICAL TRIAL; DENSITY; DILUTION; DRUG FORMULATION; HUMAN; PH; PRIORITY JOURNAL; SPINAL ANESTHESIA;

EID: 0347993874     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000093244.01831.D7     Document Type: Article

References (19)

1. Foldes FF, McNall PG. 2-chloroprocaine: a new local anesthetic agent. Anesthesiology 1952;13:287-96.
2. Ravindran RS, Bond VK, Tasch MD, et al. Prolonged neural blockade following regional analgesia with 2-chloroprocaine. Anesth Analg 1980;59:447-51.
3. Reisner LS, Hockman BN, Plumer MH. Persistent neurologic deficit and adhesive arachnoiditis following intrathecal 2-chloroprocaine injection. Anesth Analg 1980;59:452-4.
4. Moore DC, Spierdijk J, van Kleef JD, et al. Chloroprocaine neurotoxicity: Four additional cases. Anesth Analg 1982;61:158-9.
5. Gissen AJ, Datta S, Lambert D. The chloroprocaine controversy: is chloroprocaine neurotoxic? Reg Anesth 1984;9:135-45.
6. Wang BC, Hillman DE, Spielholz NI, Tumdorf H. Chronic neurological deficits and Nesacaine-CE: an effect of the anesthetic, 2-chloroprocaine, or the antioxidant, sodium bisulfite? Anesth Analg 1984;63:445-7.
7. Scally DL. Review and evaluation of clinical data: special summary of adverse experiences for review by FDA Anesthetic Life Support Drug Advisory Committee, 1980.
8. Schneider M, Ettlin T, Kaufmann, M, et al. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg 1993;76:1154-7.
9. Hampl KF, Schneider MC, Pargger H, et al. A similar incidence of transient neurologic symptoms after spinal anesthesia with 2% and 5% lidocaine. Anesth Analg 1996;83:1051-4.
10. Richardson MG, Wissler RN. Density of lumbar cerebrospinal fluid in pregnant and nonpregnant humans. Anesthesiology 1996;85:326-30.
11. Richardson MG, Wissler RN. Densities of dextrose-free intrathecal local anesthetics, opioids, and combinations measured at 37°C. Anesth Analg 1997;84:95-9.
12. Horlocker TT, Wedel DJ. Density, specific gravity, and baricity of spinal anesthetic solutions at body temperature. Anesth Analg 1993;76:1015-8.
13. Sanderson P, Read J, Littlewood DG, et al. Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread. Br J Anaesth 1994;73:744-6.
14. Greene NM. Distribution of local anesthetic solutions within the subarachnoid space. Anesth Analg 1985;64:715-30.
15. Stienstra R, Gielen M, Kroon JW, Van Poorten F. The influence of temperature and spread of injection on the distribution of a solution containing bupivacaine and methylene blue in a spinal canal model. Reg Anesth 1990;15:6-11.
16. Peterfreund RA, Datta S, Ostheimer GW. pH adjustment of local anesthetic solutions with sodium bicarbonate: laboratory evaluation of alkalinization and precpitation. Reg Anesth 1989;14:265-70.
17. Redick LF. pH adjustment of chloroprocaine solutions. Anesth Analg 1987;66:283-6.
18. Crews JC, Clark RB. Effect of alkalinization on the pH of local anesthetic solutions. Anesth Analg 1987;66:1196-205.
19. Stevens RA, Chester WL, Schubert A, et al. pH-adjustment of 2-chloroprocaine quickens the onset of epidural anaesthesia. Can J Anaesth 1989;36:515-8.